Atlas Trials

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis

Clinical trial NCT01856803 · COMPLETED

Trial details

NCT number
NCT01856803
Sponsor
Peking University People's Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Leukemia, GVHD, ATG, Transplantation
Start date
2013-10-01
Primary completion
2018-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.